학술논문
Adverse events of after-loading high dose rate brachytherapy reported to the United States Food and Drug Administration (FDA)
Document Type
Article
Author
Source
In Brachytherapy September-October 2021 20(5):1053-1061
Subject
Language
ISSN
1538-4721